Abstract The 5th European Conference on Infections in Leukaemia (ECIL-5) meeting aimed
to establish evidence-based recommendations for the prophylaxis of Pneumocystis jirovecii …

Despite major improvements in outcome over the past decades, acute myeloid leukemia
(AML) remains a life-threatening malignancy in children, with current survival rates of∼ …

With increasing numbers of immune-compromised patients with malignancy, hematologic
disease, and HIV, as well as those receiving immunosupressive drug regimens for the …

The study of human hematopoietic cells and the human immune system is hampered by the
lack of a suitable experimental model. Experimental data are presented showing that human …

This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and
Neutropenia Guidelines Panel, updates guidelines established a decade ago by the …

Background Pneumocystis pneumonia (PCP) is a disease affecting immunocompromised
patients. PCP among these patients is associated with significant morbidity and mortality …

Objective To determine the clinical spectrum of immunosuppressive conditions and systemic
corticosteroid therapy associated with the development of Pneumocystis carinii pneumonia …

Acute lymphoblastic leukemia (ALL) is diagnosed in 3000 to 4000 persons in the United
States each year; two thirds of them are children. 1, 2 The current rate of cure of nearly 80 …

P neumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with
cancer‐related immunosuppression. There are well‐defined patients who are at risk of PJP …

Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …